www.pinksheets.com/pink/quote/quote.jsp?symbol=GNTA
**************************************************
May 06, 2009 (M2 PRESSWIRE via COMTEX) -- -www.companiesandmarkets.com adds new report: Genta Incorporated - Financial and Strategic Analysis Review
Genta Incorporated - Financial and Strategic Analysis Review
Summary
Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. The company's lead product candidate is Ganite, indicated for the treatment of clearly symptomatic cancer-related hypercalcemia. The company operates through its single reportable segment namely; Oncology. The company's research portfolio consists of two major programs: DNA/RNA Medicines and Small Molecules.
This report presents an in-depth business, strategic and financial analysis of Genta Incorporated. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and views on the company.
Scope
-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
-The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
-A quick "one-stop-shop" to understand the company.
-Enhance business/sales activities by understanding customers' businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers - with key data on their businesses and locations.
-Capitalize on competitors' weaknesses and target the market opportunities available to them.
-Compare your company's financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
www.companiesandmarkets.com/link.asp?id=M9OJWJD2274169
CONTACT: Mike King, Director, www.companiesandmarkets.com Tel: +44 7813 784 393 Fax: +44 1536 790 144 e-mail: info@companiesandmarkets.com WWW: www.companiesandmarkets.com/link.asp?id=M9OJWJD2274169
Zurück
Weiter
